Cornerstone Financial Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.26K Buy
27
+6
+29% +$1.24K ﹤0.01% 608
2026
Q1
$4.71K Buy
21
+6
+40% +$1.5K ﹤0.01% 495
2025
Q4
$3.61K Buy
+15
New +$3.84K ﹤0.01% 508

Other funds holding RMD

Cornerstone Financial Management's RMD Position: Q2 2026 in Review

Cornerstone Financial Management increased its ResMed (RMD) stake by 29% in Q2 2026, buying an estimated $1.24K and bringing the position to 27 shares worth $5.26K. The position accounts for ﹤0.01% of the portfolio, ranked #608.

Cornerstone Financial Management first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Cornerstone Financial Management held 27 shares of ResMed worth $5.26K as of Q2 2026.
  • Cornerstone Financial Management bought 6 ResMed shares in Q2 2026, an estimated $1.24K.
  • ResMed made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #608 holding.
  • Cornerstone Financial Management first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.